- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Stem Cells International
Volume 2013 (2013), Article ID 678063, 5 pages
Biodistribution of Mesenchymal Stem/Stromal Cells in a Preclinical Setting
1UMR5273 CNRS, UPS, EFS—INSERM U1031, STROMALab, Toulouse, France
2EFS Pyrénées-Méditerranée, Toulouse, France
Received 14 May 2013; Accepted 8 July 2013
Academic Editor: Mauro Krampera
Copyright © 2013 Luc Sensebé and Sandrine Fleury-Cappellesso. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. J. Friedenstein, J. F. Gorskaja, and N. N. Kulagina, “Fibroblast precursors in normal and irradiated mouse hematopoietic organs,” Experimental Hematology, vol. 4, no. 5, pp. 267–274, 1976.
- A. I. Caplan, “The mesengenic process,” Clinics in Plastic Surgery, vol. 21, no. 3, pp. 429–435, 1994.
- R. Quarto, M. Mastrogiacomo, R. Cancedda et al., “Repair of large bone defects with the use of autologous bone marrow stromal cells,” New England Journal of Medicine, vol. 344, no. 5, pp. 385–386, 2001.
- Y. Takashima, T. Era, K. Nakao et al., “Neuroepithelial cells supply an initial transient wave of MSC differentiation,” Cell, vol. 129, no. 7, pp. 1377–1388, 2007.
- M. Crisan, S. Yap, L. Casteilla et al., “A perivascular origin for mesenchymal stem cells in multiple human organs,” Cell Stem Cell, vol. 3, no. 3, pp. 301–313, 2008.
- M. Dominici, K. le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006.
- D. A. de Ugarte, K. Morizono, A. Elbarbary et al., “Comparison of multi-lineage cells from human adipose tissue and bone marrow,” Cells Tissues Organs, vol. 174, no. 3, pp. 101–109, 2003.
- D. G. Phinney and L. Sensebé, “Mesenchymal stromal cells: misconceptions and evolving concepts,” Cytotherapy, vol. 15, pp. 140–145, 2013.
- K. le Blanc, I. Rasmusson, B. Sundberg et al., “Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells,” The Lancet, vol. 363, no. 9419, pp. 1439–1441, 2004.
- J. Tan, W. Wu, X. Xu et al., “Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial,” Journal of the American Medical Association, vol. 307, no. 11, pp. 1169–1177, 2012.
- D. G. Phinney and D. J. Prockop, “Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views,” Stem Cells, vol. 25, no. 11, pp. 2896–2902, 2007.
- M. Breitbach, T. Bostani, W. Roell et al., “Potential risks of bone marrow cell transplantation into infarcted hearts,” Blood, vol. 110, no. 4, pp. 1362–1369, 2007.
- F. Djouad, P. Plence, C. Bony et al., “Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals,” Blood, vol. 102, no. 10, pp. 3837–3844, 2003.
- J. Houghton, H. Li, X. Fan et al., “Mutations in bone marrow-derived stromal stem cells unmask latent malignancy,” Stem Cells and Development, vol. 19, no. 8, pp. 1153–1166, 2010.
- G. Bouchez, L. Sensebé, P. Vourc'h et al., “Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease,” Neurochemistry International, vol. 52, no. 7, pp. 1332–1342, 2008.
- M. Bensidhoum, A. Chapel, S. Francois et al., “Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment,” Blood, vol. 103, no. 9, pp. 3313–3319, 2004.
- A. Gholamrezanezhad, S. Mirpour, M. Bagheri et al., “In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis,” Nuclear Medicine and Biology, vol. 38, no. 7, pp. 961–967, 2011.
- E. Wolfs, T. Struys, T. Notelaers et al., “18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastrucute and differentiation capacity.,” Journal of Nuclear Medicine, vol. 54, pp. 447–454, 2013.
- M. Vilalta, I. R. Dégano, J. Bagó et al., “Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging,” Stem Cells and Development, vol. 17, no. 5, pp. 993–1004, 2008.
- Y.-K. Chang, Y.-P. Liu, J. H. Ho, S.-C. Hsu, and O. K. Lee, “Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 30, pp. 1499–1506, 2012.
- G. Schmidtke-Schrezenmeier, M. Urban, A. Musyanovych et al., “Labeling of mesenchymal stromal cells with iron oxidepoly(l-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging properties,” Cytotherapy, vol. 13, no. 8, pp. 962–975, 2011.
- K. Toupet, M. Maumus, J.-A. Peyrafitte et al., “Long-term detection of human adipose derived mesenchymal stem cells after intra-articular injection,” Arthritis & Rheumatism, vol. 65, no. 7, pp. 1786–1794, 2013.
- R. H. Lee, A. A. Pulin, M. J. Seo et al., “Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6,” Cell Stem Cell, vol. 5, no. 1, pp. 54–63, 2009.
- M. G. Manz and J. P. di Santo, “Renaissance for mouse models of human hematopoiesis and immunobiology,” Nature Immunology, vol. 10, no. 10, pp. 1039–1042, 2009.
- M. Mouiseddine, S. François, A. Semont et al., “Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model,” British Journal of Radiology, vol. 80, no. 1, pp. S49–S55, 2007.
- C. Allers, W. D. Sierralta, S. Neubauer, F. Rivera, J. J. Minguell, and P. A. Conget, “Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice,” Transplantation, vol. 78, no. 4, pp. 503–508, 2004.
- A. Chapel, J. M. Bertho, M. Bensidhoum et al., “Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome,” Journal of Gene Medicine, vol. 5, no. 12, pp. 1028–1038, 2003.
- B. Mitkari, E. Kerkelä, J. Nystedt et al., “Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats,” Experimental Neurology, vol. 239, pp. 158–162, 2013.
- J.-K. Yoon, B.-N. Park, W.-Y. Shim, J. Y. Shin, G. Lee, and Y. H. Ahn, “In vivo tracking of 111In-labeled bone marrow mesenchymal stem cells in acute brain trauma model,” Nuclear Medicine and Biology, vol. 37, no. 3, pp. 381–388, 2010.
- Y. Ramot, M. Meiron, A. Toren, M. Steiner, and A. Nyska, “Safety and biodistribution profile of Placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery,” Toxicologic Pathology, vol. 37, no. 5, pp. 606–616, 2009.
- A. Bouacida, P. Rosset, V. Trichet et al., “Pericyte-like progenitors show high immaturity and engraftment potential as compared with mesenchymal stem cells,” PLoS One, vol. 7, no. 11, Article ID e48648, 2012.
- O. Ringdén, M. Uzunel, I. Rasmusson et al., “Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease,” Transplantation, vol. 81, no. 10, pp. 1390–1397, 2006.